Cargando…
Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895889/ http://dx.doi.org/10.1016/j.jaci.2022.12.085 |
_version_ | 1784881943533322240 |
---|---|
author | Dluzynski, Daniela Al-Shaikhly, Taha Henao, Maria Paula |
author_facet | Dluzynski, Daniela Al-Shaikhly, Taha Henao, Maria Paula |
author_sort | Dluzynski, Daniela |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9895889 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Published by Mosby, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98958892023-02-06 Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic Dluzynski, Daniela Al-Shaikhly, Taha Henao, Maria Paula J Allergy Clin Immunol Article Published by Mosby, Inc. 2023-02 2023-02-03 /pmc/articles/PMC9895889/ http://dx.doi.org/10.1016/j.jaci.2022.12.085 Text en Copyright © 2022 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Dluzynski, Daniela Al-Shaikhly, Taha Henao, Maria Paula Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic |
title | Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic |
title_full | Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic |
title_fullStr | Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic |
title_full_unstemmed | Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic |
title_short | Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic |
title_sort | tixagevimab-cilgavimab rollout on common variable immunodeficient patients: early lessons from an academic allergy and immunology clinic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895889/ http://dx.doi.org/10.1016/j.jaci.2022.12.085 |
work_keys_str_mv | AT dluzynskidaniela tixagevimabcilgavimabrolloutoncommonvariableimmunodeficientpatientsearlylessonsfromanacademicallergyandimmunologyclinic AT alshaikhlytaha tixagevimabcilgavimabrolloutoncommonvariableimmunodeficientpatientsearlylessonsfromanacademicallergyandimmunologyclinic AT henaomariapaula tixagevimabcilgavimabrolloutoncommonvariableimmunodeficientpatientsearlylessonsfromanacademicallergyandimmunologyclinic |